ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

XFOR vs ALEC // RETURN ON INVESTED CAPITAL (ROIC)

X4 Pharmaceuticals Inc. (NASDAQ) VS. Alector Inc. (NASDAQ) • 15-METRIC TALLY: XFOR 3 — ALEC 1
■ METRIC PARITY
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (XFOR VS. ALEC) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC XFOR ALEC SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin 83.60% — — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) ACTIVE -35.00% -35.00% 0.00 TIE /roic <GO>
EV/EBITDA & P/E Valuation — — — TIE /valuation <GO>
Free Cash Flow Yield — — — TIE /fcf-yield <GO>
Operating Margin -60.00% -60.00% 0.00 TIE /operating-margins <GO>
Net Profit Margin -60.00% -60.00% 0.00 TIE /net-margins <GO>
Revenue Growth (YoY) 180.00% -65.00% +245.00 XFOR /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity 0.20 0.20 0.00 TIE /balance-sheet <GO>
Piotroski F-Score Quality 3/9 2/9 +1.00 XFOR /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 60.3 60.4 -0.08 ALEC /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $333.1M $332.1M $1.0M XFOR /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR XFOR REV ALEC REV XFOR GROSS % ALEC GROSS % XFOR FCF ALEC FCF
FY 2025 $35.1M $21.0M 83.6% — -$85.6M -$184.1M
FY 2024 $2.6M $100.6M 68.8% — -$131.2M -$231.2M
FY 2023 $0 $97.1M — — -$96.5M -$184.2M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
XFOR // BETA —
ALEC // BETA —